Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.21.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Sep. 30, 2021
Dec. 31, 2020
Current Assets    
Cash and cash equivalents $ 16,133,652 $ 21,531,665
Other receivables 110,000 0
Prepaid expenses and other current assets 247,211 172,460
Total Current Assets 16,490,863 21,704,125
Other Assets    
Trademarks 101,583 85,562
Total Assets 16,592,446 21,789,687
Current Liabilities    
Accounts payable and accrued liabilities 1,107,865 382,130
Accrued legal settlement costs 0 4,200,000
Total Current Liabilities 1,107,865 4,582,130
Stockholders' Equity    
Preferred stock, $0.001 par value, 10,000,000 authorized shares 0 0
Common stock, $0.001 par value, 13,500,000 shares authorized, 7,208,739 shares and 6,567,110 shares issued and outstanding at September 30, 2021 and December 31, 2020, respectively 7,209 6,567
Additional paid-in capital 150,163,990 146,353,232
Accumulated deficit (134,689,948) (129,155,608)
Total Stockholders' Equity 15,484,581 17,207,557
Total Liabilities and Stockholders' Equity 16,592,446 21,789,687
Convertible Series A [Member]    
Stockholders' Equity    
Convertible Series A preferred shares, 663,767 shares and 699,878 shares issued and outstanding at September 30, 2021 and December 31, 2020, respectively (liquidation preference $2,614,186 and $2,613,025 at September 30, 2021 and December 31, 2020, respectively) 663 699
Convertible Series B Preferred Stock [Member]    
Stockholders' Equity    
Convertible Series B preferred shares, 2,666,667 shares issued and outstanding at September 30, 2021 and December 31, 2020 (liquidation preference $5,159,162 and $4,897,517 at September 30, 2021 and December 31, 2020, respectively) $ 2,667 $ 2,667